Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.CEMI · Entity 114014 | Director | March 16, 2020 | March 18, 2020 |
| QuidelOrtho CorpQDEL · Entity 4986 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMBIO DIAGNOSTICS, INC.
Report date March 16, 2020 · Filed March 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 16,314 |
Reported balance
After 2020-03-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-03-16 · Grant · Acquired 16,314 · Balance 16,314 F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F2: The restricted stock units are scheduled to vest in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer). |
| Option to purchaseSEC Table II · derivative / convertible security · Conversion / exercise price $2.36 · Expires 2027-03-15 | Direct | 36,252 |
Reported balance
After 2020-03-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-16 · Grant · Acquired 36,252 · Balance 36,252 F3: The option is scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock.
F2: The restricted stock units are scheduled to vest in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer).
F3: The option is scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control.
QuidelOrtho Corp
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (Equity Grant)SEC Table II · derivative / convertible security | Direct | 15,532 |
Reported balance
After 2026-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 15,532 · Balance 15,532 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: The restricted stock units will vest on June 25, 2027. |
| Restricted Stock Units (Converted)SEC Table II · derivative / convertible security | Direct | 5,547 |
Reported balance
After 2026-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-25 · Grant · Acquired 5,547 · Balance 5,547 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. |
| Restricted Stock Units (Premium)SEC Table II · derivative / convertible security | Direct | 1,664 |
Reported balance
After 2026-06-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-25 · Grant · Acquired 1,664 · Balance 1,664 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: The restricted stock units will vest on June 25, 2027. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2: The restricted stock units will vest on June 25, 2027.
F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
F4: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 1
1 source rowRow 1 · 2022-05-27 · Disposition to issuer · Disposed 20,653 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-27 · Disposition to issuer · Disposed 1,954 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-27 · Disposition to issuer · Disposed 1,218 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Disposition to issuer · Disposed 1,572 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 1,419 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 875 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 262 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 273 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 82 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 427 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 128 · Balance 0 F2: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F4: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Premium) · Derivative | 1,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000005 · wk-form4_1782770339.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,664 Underlying: Common Stock · 1,664 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Converted) · Derivative | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000005 · wk-form4_1782770339.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,547 Underlying: Common Stock · 5,547 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000005 · wk-form4_1782770339.xml · derivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · nonDerivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,442 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,218 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000002 · wk-form4_1780431016.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000002 · wk-form4_1780431016.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,469 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 21:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | PurchaseCommon Stock | 1,000 | $22.43 | $22,430.00 |
DisclosureSEC source: 0001187716-25-000006 · wk-form4_1764018554.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,640 Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:26 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Premium) · Derivative | 731 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000130 · wk-form4_1748896009.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 731 Underlying: Common Stock · 731 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on May 29, 2026. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:26 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Converted) · Derivative | 2,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000130 · wk-form4_1748896009.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,439 Underlying: Common Stock · 2,439 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 609 shares vested on May 29, 2025, 610 shares will vest on August 29, 2025, 610 shares will vest on November 29, 2025 and 610 shares will vest on February 28, 2026. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 609 shares vested on May 29, 2025, 610 shares will vest on August 29, 2025, 610 shares will vest on November 29, 2025 and 610 shares will vest on February 28, 2026. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:26 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000130 · wk-form4_1748896009.xml · derivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,829 Underlying: Common Stock · 6,829 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on May 29, 2026. F2 · derivative.expiration_date: The restricted stock units will vest on May 29, 2026. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:24 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000097 · wk-form4_1748377492.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:24 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000097 · wk-form4_1748377492.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,640 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · nonDerivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,711 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,583 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:38 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066003 · ownership.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units vested on May 24, 2024. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:38 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066003 · ownership.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,156 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:32 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Premium) · Derivative | 528 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-064156 · ownership.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 528 Underlying: Common Stock · 528 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 22, 2025. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:32 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Converted) · Derivative | 1,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-064156 · ownership.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,760 Underlying: Common Stock · 1,760 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 440 shares vested on May 22, 2024, 440 shares will vest on August 22, 2024, 440 shares will vest on November 22, 2024 and 440 shares will vest on February 22, 2025. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 440 shares vested on May 22, 2024, 440 shares will vest on August 22, 2024, 440 shares will vest on November 22, 2024 and 440 shares will vest on February 22, 2025. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:32 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-064156 · ownership.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,929 Underlying: Common Stock · 4,929 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 22, 2025. F2 · derivative.expiration_date: The restricted stock units vest on May 22, 2025. Read SEC document |
| May 12, 2024 Filed May 14, 2024 21:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-059822 · ownership.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 12, 2024 Filed May 14, 2024 21:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-059822 · ownership.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 12, 2024 Filed May 14, 2024 21:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-059822 · ownership.xml · nonDerivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,040 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 12, 2024 Filed May 14, 2024 21:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-059822 · ownership.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,958 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:22 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035391 · doc4.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:22 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035391 · doc4.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,685 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Premium) · Derivative | 241 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032328 · doc4.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241 Underlying: Common Stock · 241 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Converted) · Derivative | 805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032328 · doc4.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805 Underlying: Common Stock · 805 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032328 · doc4.xml · derivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 262 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · nonDerivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,437 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,175 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Premium) · Derivative | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035177 · doc4.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224 Underlying: Common Stock · 224 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Converted) · Derivative | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035177 · doc4.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749 Underlying: Common Stock · 749 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, June 6, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, June 6, 2022. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035177 · doc4.xml · derivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 11 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 10 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 427 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 9 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 8 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 273 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 7 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 262 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 6 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 875 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 1,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,419 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,572 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 1,218 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,218 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:26 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 1,954 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020407 · doc4.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,954 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.